The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
i'm aware but they're not as profitable as long haul flights that's their business model
they are trying to change but short term, it's not going to be a huge revenue/profit boost.
govt might need to intervene at some point but considering it's the tories - i doubt it
glad i took the small 4% loss - they might even need to do another raise in order to keep things going, further dilute current holders
not looking good at all
RR specialism is long haul flights don't see that getting back to normal anytime soon even a "Europe travel bubble" is being pushed back towards the end of the year
it just keeps falling! omg
Company raise
he's raising funds to stick in his own pocket? am i right folks?
i've been in and out of AVCT it was pretty clear Saliva does not pick up enough viral load and considering how many competing companies there are it was unlikely AVCT would have been successful and LOOK WHERE WE ARE FOLKS! folks would prefer a saliva test over a nasal swab any day of the week.
BIG ALS SOLD HIS SHARES!
I would sit it out - don't borrow money - hope a vaccine works and planes start flying again - i'm optimistic will see a strong bounce in 2021. Don't see RR going under, govt is right behind it but does not want to intervene it is strategically important to the UK.
GL